Shares of ValiRx plc (LON:VAL – Get Free Report) traded up 24.8% on Tuesday . The stock traded as high as GBX 0.80 ($0.01) and last traded at GBX 0.78 ($0.01). 6,398,107 shares changed hands during mid-day trading, an increase of 353% from the average session volume of 1,411,171 shares. The stock had previously closed at GBX 0.63 ($0.01).
ValiRx Stock Up 2.3 %
The stock has a 50-day moving average price of GBX 1.29 and a 200-day moving average price of GBX 1.90. The company has a debt-to-equity ratio of 0.49, a current ratio of 6.65 and a quick ratio of 1.27. The company has a market capitalization of £1.05 million, a P/E ratio of -39.65 and a beta of 0.59.
About ValiRx
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of end-stage non-small cell lung cancer.
Further Reading
- Five stocks we like better than ValiRx
- Differences Between Momentum Investing and Long Term Investing
- Work and Play: Investing in the Rise of Bleisure Travel
- Consumer Staples Stocks, Explained
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- How to Calculate Options Profits
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
